多替阿巴拉米片列入医保了吗？

In January 2018, it officially entered the Chinese market. According to Medical Companion Travel, because Dolutegra Abalamid Tablets are imported original drugs in China and are very expensive, most patients cannot afford them. Therefore, many patients want to know whether Dolutegra Abalamid Tablets is included in medical insurance?

It is reported that Suimeikai has not been included in domestic medical insurance and is a self-pay drug for patients. In fact, patients can choose Suimeikai, which is available in India. Suimeikai, produced by the Indian company Emcure, comes in a box of 30 tablets and sells for about RMB 1,000. The price cannot be determined due to the floating exchange rate. Please consult Medical Travel for the specific price.

On July 26, the China Food and Drug Administration (CFDA) approved a new compound preparation for the treatment of AIDS, Trimecaid (chemical name: doteabalamid tablet), to enter China. As an innovative single-chip compound preparation with obvious clinical therapeutic advantages, Trimecaid can provide great convenience for the treatment of AIDS patients and has received priority approval from the State Food and Drug Administration. The anti-AIDS single-tablet compound drug doptabalamid tablets have been marketed and approved by the State Food and Drug Administration, bringing new drug options to Chinese AIDS patients.

Dr. Wim Swyzen, MD, head of medical affairs and vice president of GSK China\Hong Kong, said, "Through effective HIV drug treatment, we can see that the life spans of AIDS patients and healthy people are getting closer and closer. Therefore, drug compliance and convenience of medication play an increasingly important role in further improving the quality of life of patients. Currently, there is no drug that can be taken once a day, one tablet at a time, on the Chinese market. The approval of the drug fills this gap and meets the urgent need for convenient medication use by doctors and patients."